- The primary objective of this study is to evaluate the efficacy of modafinil in the
treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS).
- The secondary objective is to estimate the frequency and severity of toxicity associated
with Modafinil (400mg) in patients with opioid induced sedation.
Phase:
Phase 3
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins